GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Orient Pharma Co 4166.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

22.55

+2.50%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.40bn

FY2016FY2025

Net income

TWD 208.4m

FY2016FY2025

Free cash flow

TWD 310.4m

FY2016FY2025

Shareholders' equity

TWD 2.56bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.40bnTWD 1.22bnTWD 889.9mTWD 511.9mTWD 463.3mTWD 412.0mTWD 353.5mTWD 269.5mTWD 229.1mTWD 274.4m
Gross profitTWD 790.7mTWD 651.6mTWD 468.7mTWD 155.3mTWD 142.7mTWD 75.2mTWD 13.7mTWD 5.7m−TWD 36.0mTWD 26.2m
Research and developmentTWD 79.9mTWD 103.7mTWD 99.9mTWD 129.3mTWD 219.7mTWD 183.9mTWD 153.6mTWD 185.8mTWD 214.2mTWD 191.5m
Operating incomeTWD 267.1mTWD 173.9mTWD 40.3m−TWD 34.8m−TWD 104.9m−TWD 160.7m−TWD 205.4m−TWD 249.1m−TWD 308.7m−TWD 229.0m
Net incomeTWD 208.4mTWD 107.4mTWD 22.3m−TWD 28.8m−TWD 102.7m−TWD 171.4m−TWD 201.0m−TWD 160.1m−TWD 264.8m−TWD 198.9m
Diluted earnings per share0.860.480.10-0.15-0.55-1.01-1.29-0.94-1.77-1.34

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.94bnTWD 2.52bnTWD 2.56bnTWD 1.85bnTWD 1.76bnTWD 1.74bnTWD 1.56bnTWD 1.52bnTWD 1.66bnTWD 1.48bn
Cash and short-term investments——TWD 113.1mTWD 97.2mTWD 151.7mTWD 190.4mTWD 58.1mTWD 127.7mTWD 379.4mTWD 229.3m
Total liabilitiesTWD 374.9mTWD 733.0mTWD 892.2mTWD 757.7mTWD 647.9mTWD 526.4mTWD 1.6mTWD 344.2mTWD 331.6mTWD 392.1m
Debt—TWD 546.5mTWD 716.9mTWD 508.1mTWD 415.0mTWD 323.7mTWD 367.3mTWD 145.8mTWD 167.9mTWD 244.4m
Shareholders' equityTWD 2.56bnTWD 1.79bnTWD 1.67bnTWD 1.09bnTWD 1.12bnTWD 1.22bnTWD 985.2mTWD 1.18bnTWD 1.33bnTWD 1.09bn
Shares outstanding243m226m223m187m187m169m156m171m149m149m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 359.9mTWD 195.7m−TWD 103.0mTWD 11.4m−TWD 53.6m−TWD 148.0m−TWD 129.9m−TWD 205.3m−TWD 227.5m−TWD 172.5m
Capital spending−TWD 49.5m−TWD 27.4m−TWD 73.5m−TWD 28.9m−TWD 70.0m−TWD 74.4m−TWD 25.4m−TWD 20.7m−TWD 39.3m−TWD 9.7m
Free cash flowTWD 310.4mTWD 168.3m−TWD 176.5m−TWD 17.5m−TWD 123.6m−TWD 222.4m−TWD 155.3m−TWD 226.0m−TWD 266.7m−TWD 182.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 427.1mTWD 331.2mTWD 441.8mTWD 316.1mTWD 325.5mTWD 316.9mTWD 319.2mTWD 300.6m
Gross profitTWD 225.4mTWD 185.0mTWD 265.5mTWD 176.4mTWD 183.6mTWD 165.2mTWD 175.0mTWD 140.8m
Operating incomeTWD 85.2mTWD 47.8mTWD 103.9m—TWD 53.2m—TWD 37.8mTWD 5.9m
Net incomeTWD 57.4mTWD 38.7mTWD 91.8mTWD 47.3mTWD 18.8mTWD 50.6mTWD 11.4m−TWD 1.0m
Diluted earnings per share0.240.160.380.190.080.230.05-0.00
Cash from operationsTWD 52.0mTWD 74.0mTWD 101.0mTWD 63.0mTWD 68.0mTWD 126.0mTWD 59.0m—
Capital spending−TWD 30.0m−TWD 29.0m−TWD 17.0m−TWD 26.0m−TWD 2.0m−TWD 3.0m−TWD 11.0m−TWD 3.0m
Free cash flowTWD 22.0mTWD 45.0mTWD 84.0mTWD 37.0mTWD 66.0mTWD 123.0mTWD 48.0m—
Total assetsTWD 3.01bnTWD 2.95bnTWD 2.94bnTWD 2.89bnTWD 2.55bnTWD 2.54bnTWD 2.52bn—
Debt————TWD 22.8mTWD 32.5mTWD 42.1m—
Shareholders' equityTWD 2.66bnTWD 2.60bnTWD 2.56bnTWD 2.47bnTWD 1.86bnTWD 1.84bnTWD 1.79bn—

Financial ratios

Data as of 13 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin66.1%53.3%52.7%30.3%30.8%18.2%
Operating margin18.0%14.5%4.5%-6.6%-22.5%-38.9%
Net margin14.9%8.8%2.5%-5.6%-22.2%-41.6%
Return on equity8.1%6.0%1.3%-2.6%-9.2%-14.1%
Return on assets7.1%4.3%0.9%-1.6%-5.8%-9.8%
Free cash flow yield—4.1%-0.5%0.9%——
Revenue growth14.5%37.4%73.9%10.5%12.5%16.5%
Earnings growth94.1%381.8%-177.5%-72.0%-40.1%-14.7%
Current ratio6.73x1.49x1.10x1.21x1.05x1.73x
Debt to equity0.00x0.02x0.30x0.26x0.27x0.17x
Equity ratio87.2%70.9%65.2%59.0%63.3%69.8%
Interest coverage31.93x12.68x2.90x-4.57x-18.31x-29.81x
R&D as a share of sales5.7%8.5%11.2%25.3%47.4%44.6%
Buybacks as a share of market value—-1.2%-19.3%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue39.9%27.7%24.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.0%51.3%46.6%36.7%
Operating margin16.8%11.1%3.7%-17.2%
Net margin12.0%7.7%0.7%-16.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings30.575.4198.6-135.6-33.7-14.4-11.2-16.7-10.2-21.8
Price to sales4.56.65.07.67.56.06.49.911.815.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.